Data / Form D filings / Amydis, Inc.
Amydis, Inc.: Form D filings
Amydis, Inc., a biotechnology company in Los Angeles, CA, filed 3 Form D notices with the SEC between 2022 and 2023. The latest, on December 28, 2023, reports $3 million sold of a $6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1901 Avenue of the Stars, SUITE 200, Los Angeles, CA, 90067
- Phone
- (310) 229-5710
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1924488
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 28, 2023 | New notice | $6,000,000 | $3,000,000 | $3,000,000 | 1 | Dec 14, 2023 | sec.gov |
| Dec 29, 2022 | New notice | $9,000,000 | $5,999,991 | $3,000,009 | 2 | Dec 20, 2022 | sec.gov |
| Apr 22, 2022 | New notice | $5,685,732 | $5,685,732 | 14 | Feb 16, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christine Aylward | Director | |
| Mervyn Turner | Director | |
| Stella Sarraf | Executive Officer, Director | |
| James Khodabakhsh | Director | |
| Jerre L. Stead | Director | |
| Jack L. Thrift, CPA | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 25, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Amydis, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.